Lumateperone for Late-Life Depression

NCT ID
NCT07623135
Registry status
Recruiting
Study type
Not specified in the registry data
Phase
Phase 3
Sponsor
Eric Lenze

Overview

ClinicalTrials.gov lists this study as Recruiting.

Enrollment: 100 participants (Estimated).

What is being studied

No interventions are listed in the registry data.

Who may be eligible

Ages
Not specified in the registry data
Sex
Not specified in the registry data
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Age \>=60 * Current unipolar non-psychotic major depression determined by SCID-5 * MADRS score \>=20 at screening and \>=18 at baseline * Treatment-resistance defined as documented history of non-response to at least two oral medications of adequate dose and duration in this episode or previous episode, OR clinician determination that treatment augmentation is appropriate * Currently taking oral antidepressant prescribed at least minimum therapeutic dose and for at least six weeks duration * MMSE score of \>/=24 Exclusion Criteria: * Dementia * High risk for suicide, defined as a 4 or 5 on C-SSRS (indicating active suicidal ideation with current or recent intent or plan), and unable to be managed safely in the clinical trial. Urgent psychiatric referral will be made in these cases. * High risk alcohol use: defined as a score of 6 or more on the AUDIT-C * Medically inappropriate for participation as determined by PIs.

Study locations

2 study locations are listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: United States

  • Arizona, United States: 1
  • Missouri, United States: 1

Sample of listed locations

  • University of Arizona — Tucson, Arizona, 85713, United States — Site recruitment status not specified in the registry data
  • Washington University School of Medicine — St Louis, Missouri, 63110, United States — Site recruitment status not specified in the registry data

Study details

Start date
September 1, 2026
Primary completion date
June 1, 2028
First posted
June 3, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07623135
Registry last updated
September 16, 2026
QualifiedStudies registry data refreshed
September 21, 2026

View NCT07623135 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Depression studies | Clinical trial FAQ